Study: CardioMEMs implanted heart monitor safe for renal failure patients

New data from CardioMEMs CHAMPION clinical trial shows that the company's implanted pulmonary artery pressure monitor helps reduce heart failure hospitalizations without compromising kidney function in patients with renal failure. St. Jude Medical (NYSE:STJ) subsidiary CardioMEMs touted new study results this week showing that its implanted heart monitor is safe and effective in patients with chronic kidney disease. CardioMEMS Inc., St. Jude MedicalNews Well, Clinical Trials, Cardiovascular, Implants, Renalread more
Source: Mass Device - Category: Medical Equipment Authors: Source Type: news